Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Clovis Oncology
company
About
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments.
- 251 - 500
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $145M
- Industries
- Biopharma
- Founded date
- Jan 1, 2009
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$145M
Clovis Oncology has raised a total of
$145M
in funding over 2 rounds. Their latest funding was raised on
May 21, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 21, 2009 | Series Unknown | $145M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Clovis Oncology is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
